Q1 2026

Coca-Cola beats Q1 expectations with 10% organic revenue growth and raises full-year guidance, reinforcing its dividend aristocrat status with a 2.7% yield backed by strong cash flow.

$ENSG to report Q1 2026 results April 30, with management webcast May 1 at 10 a.m. PT to discuss quarterly performance.

Uwharrie Capital Corp reported Q1 2026 net income of $3.2M, up 23% from prior year. EPS increased to $0.43; assets grew to $1.25B.

L.B. Foster announces Q1 2026 earnings release May 4, pre-market, with 8:30 A.M. ET conference call discussing results and market outlook.

The Oncology Institute scheduled Q1 2026 earnings for May 7, 2026, amid reporting $1.8M Medicare savings in CMS performance program.

Newmont Mining surged 8.5% Friday after Q1 earnings beat expectations with 45.9% revenue growth and 132% EPS increase. The company authorized $6 billion in new buybacks.

Gemini Space Station reports Q1 2026 results May 14 after market close, with management conference call May 15.

Summit Hotel Properties announced $0.08 per share Q1 2026 dividend, delivering 6.8% annualized yield. Additional dividends declared for preferred shares and operating units.

IREN Limited will release Q3 FY26 financial results on May 7, 2026, with earnings call at 5:00 p.m. ET via webcast and phone.

Oakworth Capital reported 13% revenue growth in Q1 2026 driven by loan and deposit expansion, though net income declined slightly due to strategic write-downs.

Katapult Holdings will release Q1 2026 results May 7, 2026, but won't host earnings call due to pending merger with Aaron's Company and CCF Holdings.

iQIYI announces Q1 2026 earnings release for May 18, 2026, with management conference call at 7:00 AM ET. Results will be critical for assessing subscriber trends and profitability progress.

Viking Therapeutics will report Q1 2026 earnings April 29 after market close, showcasing progress on obesity and metabolic disorder treatments.

$USPH announces Q1 2026 earnings on May 6, 2026, with conference call May 7. The operator of 783 clinics across 44 states tracks financial progress.

My Personal CFO reduced its Stagwell position by 500,882 shares worth $2.8M in Q1 2026, capitalizing on 50% stock swing.

Major U.S. banks beat Q1 earnings expectations for a ninth-to-eleventh consecutive quarter, yet analysts maintain cautious price targets citing geopolitical and inflation risks.

$NHTC reports Q4 2025 net sales fell 10% YoY but rose 3% sequentially. Company targeting $1.5M annualized savings through restructuring.

Madrigal Pharmaceuticals reports Q1 2026 results May 6, revealing early commercial performance of FDA/EMA-approved MASH treatment Rezdiffra following recent regulatory clearances.

$RDVT will report Q1 2026 financial results on May 6 after market close, followed by an earnings call and business update at 4:30pm ET.

Geron Corporation will report Q1 2026 results on May 6, advancing its approved telomerase inhibitor RYTELO and Phase 3 myelofibrosis trial.